… treatment and clinical trials. The fact that our hands are empty in the battle against COVID-19,
and an urgent need for treatment, enforced us to try any possible probably safe treatment, …

… for the management of COVID-19 infection. All of the hypotheses mentioned in this review
are based on the premise that the immune responses against COVID-19 are similar to that of …

… treatment response of TCZ therapy in COVID-19 infected patients. The demographic, treatment,
… It is the other possible risk factors, not an inflammatory activity, which may attribute to the …

… COVID-19.Interim results from the WHO-led, open-label, randomised SOLIDARITY trial3 of
patients with COVID-19 … for remdesivir and other potential treatments for COVID-19. Nov 10, …

… spread of coronavirus SARS-CoV-2 causing COVID-19 across … , the high mortality rate in
COVID-19 patients without visible … lungs, may be the result of at least three possible sources: …

… COVID-19 outbreak was first recognized in Wuhan, China, in early December 2019. The
number of confirmed COVID-19 … -2 indicates severe acute respiratory syndrome coronavirus 2. …

… the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19. …
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? …

… current options for COVID-19 therapy to show that there is no specific cure for COVID-19,
and … range of promises regenerative medicine can provide for specific treatment of COVID-19. …

… the new coronavirus or coronavirus disease 2019 (COVID-19)… as Severe Acute Respiratory
Syndrome-Coronavirus-2 (SARS-… The ongoing COVID-19 pandemic with significant mortality, …

… To assess the possible entry of clinical trials of treatment for COVID-19 in more than one
clinical trial registry, we reviewed 108 clinical trial entries in the clinical trial registry with the …